Ledger.Open graph →
SEC Form D · filed January 27, 2021

NEUROONE MEDICAL TECHNOLOGIES Corp

Offering
$12.5M
Sold
$12.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EDEN PRAIRIE, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

David A. Rosa · Eden Prairie, MNExec · DirectorPaul A. Buckman · Eden Prairie, MNDirectorEdward A. Andrle · Eden Prairie, MNDirectorJeffrey S. Mathiesen · Eden Prairie, MNDirectorSteve A. Mertens · Eden Prairie, MNExecMark A. Christianson · Eden Prairie, MNExecRonald S. Mcclurg · Eden Prairie, MNExecGreg Sands · San Francisco, CADirectorKin Kee · San Francisco, CAExecKathryn A. Sykes · Tempe, AZExec · DirectorStephen Dow · Wellesley, MADirectorJohn Macilwaine · San Francisco, CADirectorBoyd Woodard · Stockton, CAExecJeffrey R. Salzsauler · Nisku, Alberta, CanadaExecPeter C. Guo · Nisku, Alberta, CanadaDirectorJanet Planet · SPARKS, NVDirectorKen Johnson · Franklin, MIExecGreg Schupra · Pontiac, MIExec · DirectorGreg Yap · New York, NYDirectorRonald S. Mcclurg · Eden Prairie, MNExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗